A Study of Nilotinib Versus Imatinib in GIST Patients
type: MedicalStudy
description: A Randomized, Open Label, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Nilotinib Versus Imatinib in Adult Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors (GIST)
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE3
start date: 2009-03
end date: 2014-10
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00785785
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Novartis Pharmaceuticals
study subject: Gastrointestinal Stromal Tumor (GIST)
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Gastrointestinal Stromal Tumor (GIST)

AI Analytics
type: Organization